Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5014894> ?p ?o }
Showing triples 1 to 23 of
23
with 100 triples per page.
- Q5014894 subject Q6814492.
- Q5014894 abstract "CXL 1020 is an experimental drug that is being investigated as a treatment for acute decompensated heart failure. CXL 1020 functions as a nitroxyl donor; nitroxyl is the reduced, protonated version of nitric oxide. Nitorxyl is capable of enhancing left ventricular contractility without increasing heart rate by modifying normal Ca2+ cycling through the sarcoplasmic reticulum as well as increasing the sensitivity of cardiac myofilaments to Ca2+.".
- Q5014894 wikiPageWikiLink Q1047227.
- Q5014894 wikiPageWikiLink Q1073121.
- Q5014894 wikiPageWikiLink Q1141325.
- Q5014894 wikiPageWikiLink Q18031341.
- Q5014894 wikiPageWikiLink Q2002035.
- Q5014894 wikiPageWikiLink Q207843.
- Q5014894 wikiPageWikiLink Q220410.
- Q5014894 wikiPageWikiLink Q220599.
- Q5014894 wikiPageWikiLink Q2919470.
- Q5014894 wikiPageWikiLink Q340240.
- Q5014894 wikiPageWikiLink Q416781.
- Q5014894 wikiPageWikiLink Q4677930.
- Q5014894 wikiPageWikiLink Q492905.
- Q5014894 wikiPageWikiLink Q5421154.
- Q5014894 wikiPageWikiLink Q6814492.
- Q5014894 wikiPageWikiLink Q6947920.
- Q5014894 wikiPageWikiLink Q79927.
- Q5014894 wikiPageWikiLink Q899488.
- Q5014894 wikiPageWikiLink Q911011.
- Q5014894 comment "CXL 1020 is an experimental drug that is being investigated as a treatment for acute decompensated heart failure. CXL 1020 functions as a nitroxyl donor; nitroxyl is the reduced, protonated version of nitric oxide. Nitorxyl is capable of enhancing left ventricular contractility without increasing heart rate by modifying normal Ca2+ cycling through the sarcoplasmic reticulum as well as increasing the sensitivity of cardiac myofilaments to Ca2+.".
- Q5014894 label "CXL 1020".